勁嘉股份(002191.SZ):子公司勁嘉新產業科技擬對佳聚電子增資2380萬元
格隆匯1月11日丨勁嘉股份(002191.SZ)公佈,2022年1月10日,經公司總經理辦公會議審議通過,同意公司全資子公司深圳勁嘉新產業科技有限公司(暫定名,具體以工商變更登記的名稱為準,簡稱“勁嘉新產業科技”)與周軍、陳曉白、深圳佳聚電子技術有限公司(簡稱“佳聚電子”)簽署《關於深圳佳聚電子技術有限公司之投資協議》,勁嘉新產業科技擬對佳聚電子增資人民幣2380萬元(其中333.3333萬元用於認繳本次新增註冊資本,其餘部分計入佳聚電子的資本公積),本次交易完成後,勁嘉新產業科技持有佳聚電子40%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.